-- title: "Emerging Swine Viral Pathogens: From Metagenomic Discovery to Point-of-Care Diagnostics" category: "livestock-viruses" metaDescription: "A technical review of metagenomic next-generation sequencing (mNGS) for novel swine virus detection and the transition to CRISPR-based and nanopore point-of-care diagnostics, integrating wet-lab validation and farm-level deployment." primaryKeyword: "emerging swine viral pathogens" secondaryKeywords: ["metagenomic next-generation sequencing", "porcine coronaviruses", "porcine circoviruses", "CRISPR diagnostics", "nanopore sequencing", "point-of-care diagnostics", "veterinary virology"]

Emerging Swine Viral Pathogens: From Metagenomic Discovery to Point-of-Care Diagnostics

Introduction

The global swine industry faces persistent threats from emerging viral pathogens that can cause severe economic losses and disrupt food supply chains. Traditional diagnostic approaches, including virus isolation, serological assays, and targeted molecular tests, often fail to detect novel or genetically divergent viruses at the early stage of an outbreak. Metagenomic next-generation sequencing (mNGS) has revolutionized the discovery of previously unknown swine viruses by enabling unbiased, high-throughput detection of all nucleic acids in a clinical sample [1]. Once a candidate pathogen is identified, rapid transition to deployable point-of-care (POC) diagnostics is critical for real-time surveillance and containment. This review examines the integrated pipeline from metagenomic discovery through portable sequencing and CRISPR-based detection, focusing on the biophysical principles, computational workflows, and practical challenges that define the current state of the field.

Metagenomic Discovery of Novel Swine Viruses

Metagenomic sequencing involves the extraction of total nucleic acids from a sample (e.g., nasal swabs, feces, tissue homogenates), followed by library preparation, high-throughput sequencing, and bioinformatic subtraction of host and commensal sequences. The remaining reads are assembled into contigs and compared against viral reference databases using algorithms such as BLAST and hidden Markov models. This approach has been instrumental in identifying novel porcine coronaviruses (e.g., swine acute diarrhea syndrome coronavirus, porcine deltacoronavirus) and emerging porcine circoviruses (e.g., PCV3, PCV4) that exhibit low sequence identity to known isolates [1].

The biophysical basis of mNGS relies on the stochastic fragmentation of DNA or cDNA, adapter ligation, and clonal amplification (bridge PCR or emulsion PCR) before sequencing by synthesis. For RNA viruses, reverse transcription is performed prior to library construction. The depth of sequencing, typically 10–50 million reads per sample, determines the sensitivity for low-abundance viral genomes. Computational pipelines such as those described in Viromics: Computational Analysis of Viral Genomes employ k-mer-based classification (e.g., Kraken2) and assembly tools (e.g., SPAdes, MEGAHIT) to reconstruct viral genomes from complex metagenomic backgrounds.

Key limitations at the discovery stage include the presence of high levels of host nucleic acid, which can overwhelm viral signals, and the inability to distinguish between infectious virions and degraded viral RNA. The use of nuclease treatment to deplete host DNA prior to extraction partially addresses this issue [1]. Furthermore, novel viruses with highly divergent genomes may be missed by reference-dependent classification, necessitating reference-free assembly strategies and phylogenetic placement using conserved protein domains The Development of BLAST: A Sequence Alignment Revolution.

Transition to Validation: Portable Nanopore Sequencing

Once a putative novel virus is identified by mNGS, confirmatory testing and real-time surveillance require technologies that can be deployed in field settings. Portable nanopore sequencers offer a solution by performing single-molecule real-time sequencing in a compact device. The technology measures changes in ionic current as DNA or RNA molecules pass through a protein nanopore embedded in a synthetic membrane Long-Read Sequencing Technologies: PacBio and Oxford Nanopore. Basecalling algorithms (e.g., Guppy, Bonito) convert raw current signals into nucleotide sequences using recurrent neural networks.

For RNA virus detection, direct RNA sequencing eliminates the need for reverse transcription and amplification, thereby reducing bias. However, the higher error rate (approximately 5–15%) compared to short-read platforms requires careful validation, often through hybrid approaches combining nanopore long reads with high-accuracy short reads from other sequencers. The portability of nanopore devices enables their use in abattoirs, quarantine stations, and on-farm settings, allowing near-real-time identification of emerging variants [1].

A typical on-site workflow involves:

• Sample homogenization and nucleic acid extraction using magnetic bead-based kits.
• Library preparation with rapid barcoding kits (approximately 10 minutes).
• Sequencing on a portable device for 1–6 hours.
• Real-time basecalling and cloud-based or edge-based bioinformatic analysis.

The integration of such workflows with epidemiological modeling Computational Modeling of Veterinary Virus Spread based on Diagnostic Data enables early outbreak detection and targeted intervention.

CRISPR-based Diagnostics: SHERLOCK and DETECTR

While sequencing provides genome-level information, its cost and turnaround time (hours to days) limit routine POC deployment. CRISPR-based diagnostics offer an alternative that combines the specificity of CRISPR-Cas nuclease activity with isothermal nucleic acid amplification, allowing detection of viral RNA or DNA in less than one hour with minimal equipment [2, 3]. The two most widely adopted platforms are SHERLOCK (Specific High-sensitivity Enzymatic Reporter Unlocking) and DETECTR (DNA Endonuclease Targeted CRISPR Trans Reporter).

SHERLOCK employs Cas13a (or Cas13b), an RNA-guided RNase that, upon target RNA binding, activates collateral cleavage of a fluorescent reporter RNA. The target RNA is first amplified by recombinase polymerase amplification (RPA) and then transcribed into RNA by T7 polymerase. Cas13a is programmed with a CRISPR RNA (crRNA) complementary to the viral sequence. The collateral cleavage generates a detectable fluorescent signal that can be read on a portable fluorometer or lateral flow strip [2, 3].

DETECTR uses Cas12a, which targets double-stranded DNA and exhibits collateral DNase activity after specific recognition. Following RPA of the viral DNA target, Cas12a cleaves a quenched fluorescent DNA reporter. This approach is particularly suited for DNA viruses such as circoviruses and can be adapted for RNA viruses by including a reverse transcription step prior to RPA.

The analytical sensitivity of both platforms typically reaches 1–10 copies per microliter, comparable to quantitative PCR Polymerase Chain Reaction (PCR) in Veterinary Diagnostics. Specificity is conferred by the crRNA sequence, which must be designed to conserved regions of the emerging virus genome. Multiplexing can be achieved using orthogonal Cas enzymes or spatially separated reactions on paper-based microfluidic devices Microfluidic Lab-on-a-Chip for Point-of-Care Veterinary Diagnostics.

Integrated Workflow: From Metagenomic Hit to POC Assay

The transition from metagenomic discovery to a validated POC diagnostic involves several iterative steps: computational identification of candidate viral sequences, wet-lab verification by PCR or sequencing, selection of conserved target regions, design and testing of crRNAs and RPA primers, and field validation against reference panels. The following diagram summarizes the decision pipeline.

flowchart TD
    A[Clinical sample collection], > B[Total nucleic acid extraction]
    B, > C[mNGS library preparation and sequencing]
    C, > D[Bioinformatic subtraction and assembly]
    D, > E{Novel viral contig identified?}
    E, >|Yes| F[Confirm by RT-PCR / qPCR]
    E, >|No| G[Return to sample collection]
    F, > H[Select conserved genomic region]
    H, > I[Design RPA primers and crRNA]
    I, > J[CRISPR assay optimization]
    J, > K{Meets sensitivity/specificity criteria?}
    K, >|Yes| L[Field validation on farm]
    K, >|No| M[Redesign primers/crRNA]
    M, > I
    L, > N[Deploy POC diagnostic]
    N, > O[Real-time surveillance data]
    O, > P[Epidemiological modeling]
    P, > Q[Outbreak response]

Each box corresponds to a physical or computational step. The iterative loop between assay optimization and redesign reflects the practical necessity of handling sequence variation in emerging viruses. For RNA viruses, the addition of a reverse transcription step before RPA is indicated.

Challenges and Future Directions

Despite the promise of this integrated pipeline, several barriers remain. First, metagenomic sequencing in low-resource settings is constrained by the cost of reagents and the need for reliable internet connectivity for bioinformatic analysis [1]. Cloud-based solutions Cloud-Based Diagnostic Data Integration for Herd Health Management can mitigate this but introduce latency in data interpretation.

Second, CRISPR diagnostics are susceptible to crRNA degradation and off-target activity, particularly when targeting hypervariable RNA viruses. Computational tools for crRNA design that incorporate secondary structure prediction and off-target scoring are under active development Guide RNA Design Algorithms for CRISPR Systems. Additionally, the collateral cleavage mechanism requires careful optimization of reporter concentration and incubation temperature to avoid background signal.

Third, the regulatory landscape for novel POC diagnostics in veterinary medicine is evolving. The World Organisation for Animal Health (WOAH) has issued guidelines for validation of diagnostic assays, but specific frameworks for CRISPR-based tests are still being established The World Organisation for Animal Health (WOAH) and Veterinary Informatics.

Future advances include the integration of electrochemical readouts for quantitative detection Electrochemical Sensors for Real-Time Veterinary Pathogen Monitoring and the use of machine learning algorithms to predict outbreak likelihood from POC surveillance data Machine Learning Algorithms for Predicting Veterinary Viral Outbreaks. The combination of portable sequencing and CRISPR diagnostics in a single "sample-to-answer" device remains a major engineering challenge.

Conclusion

The convergence of metagenomic discovery, portable long-read sequencing, and CRISPR-based diagnostics offers a powerful toolkit for combating emerging swine viral pathogens. The workflow described here enables rapid identification of novel viruses and deployment of field-deployable tests that can inform real-time control measures. Continued investment in computational infrastructure, assay standardization, and cross-sector collaboration is essential to translate these technologies from the research laboratory to routine veterinary practice.

References

[1] Nazerke K, Ruslan A, Saule D, et al. Advances and emerging technologies in the diagnosis of viral infections in pigs: Progress, challenges, and One Health perspectives. Vet World. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41716172/

[2] Gootenberg JS, Abudayyeh OO, Kellner MJ, et al. Multiplexed and portable nucleic acid detection platform with Cas13, Cas12a, and Csm6. Science. 2018;360(6387):439-444.

[3] Chen JS, Ma E, Harrington LB, et al. CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity. Science. 2018;360(6387):436-439.

[4] Palinski R, Piñeyro P, Shang P, et al. A novel porcine circovirus distantly related to known circoviruses is associated with porcine dermatitis and nephropathy syndrome and reproductive failure. J Virol. 2017;91(1):e01879-16.

[5] Pan S, Mou C, Chen Z, et al. Metagenomic sequencing and identification of a novel porcine coronavirus causing severe diarrhea in pigs. Vet Microbiol. 2020;240:108535.

[6] WHO and WOAH. Manual of Diagnostic Tests and Vaccines for Terrestrial Animals. 12th ed. Paris: World Organisation for Animal Health; 2023.

[7] Li X, Zhang Y, Wang L, et al. CRISPR-Cas13a based detection of porcine reproductive and respiratory syndrome virus. Transbound Emerg Dis. 2022;69(5):e1579-e1587.

[8] Kilianski A, Haas JL, Corriveau EJ, et al. Nanopore sequencing for rapid diagnostics of emerging pathogens. Emerg Infect Dis. 2017;23(4):680-683.